These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 8397243)

  • 1. Role of L-arginine-nitric oxide pathway in hypertension.
    Hishikawa K; Nakaki T; Suzuki H; Kato R; Saruta T
    J Hypertens; 1993 Jun; 11(6):639-45. PubMed ID: 8397243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of systemic L-arginine administration on hemodynamics and nitric oxide release in man.
    Hishikawa K; Nakaki T; Tsuda M; Esumi H; Ohshima H; Suzuki H; Saruta T; Kato R
    Jpn Heart J; 1992 Jan; 33(1):41-8. PubMed ID: 1315399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. L-arginine as an antihypertensive agent.
    Hishikawa K; Nakaki T; Suzuki H; Kato R; Saruta T
    J Cardiovasc Pharmacol; 1992; 20 Suppl 12():S196-7. PubMed ID: 1282968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of L-arginine infusion on renal hemodynamics in patients with mild essential hypertension.
    Higashi Y; Oshima T; Ozono R; Watanabe M; Matsuura H; Kajiyama G
    Hypertension; 1995 Apr; 25(4 Pt 2):898-902. PubMed ID: 7721451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of a single administration of captopril on hemodynamics and serum angiotensin converting enzyme activity, plasma renin activity and plasma aldosterone concentration in hypertensive patients.
    Hashimoto H; Hiwada K; Kokubu T
    Jpn Circ J; 1981 Feb; 45(2):176-80. PubMed ID: 6262543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of nitric oxide synthesis in salt-sensitive hypertension in Dahl/Rapp rats.
    Chen PY; Sanders PW
    Hypertension; 1993 Dec; 22(6):812-8. PubMed ID: 7503951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of nitric oxide in the arterial pressure and renal adaptations to long-term changes in sodium intake.
    Manning RD; Hu L; Reckelhoff JF
    Am J Physiol; 1997 Apr; 272(4 Pt 2):R1162-9. PubMed ID: 9140016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemodynamic, renal, and endocrine effects of acute inhibition of nitric oxide synthase in compensated cirrhosis.
    La Villa G; Barletta G; Pantaleo P; Del Bene R; Vizzutti F; Vecchiarino S; Masini E; Perfetto F; Tarquini R; Gentilini P; Laffi G
    Hepatology; 2001 Jul; 34(1):19-27. PubMed ID: 11431729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hormonal profile and participation of nitric oxide in salt-sensitive and salt-resistant essential arterial hypertension].
    Gómez-Fernández P; Moreno VG; Cornejo M; Vargas JC; García-Barroso C; Velasco G; Almaraz M
    Nefrologia; 2000; 20(5):415-23. PubMed ID: 11100662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physiological role of nitric oxide in regulation of renal function in humans.
    Haynes WG; Hand MF; Dockrell ME; Eadington DW; Lee MR; Hussein Z; Benjamin N; Webb DJ
    Am J Physiol; 1997 Mar; 272(3 Pt 2):F364-71. PubMed ID: 9087680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of L-arginine infusion on systemic and renal hemodynamics in hypertensive patients.
    Higashi Y; Oshima T; Ozono R; Matsuura H; Kambe M; Kajiyama G
    Am J Hypertens; 1999 Jan; 12(1 Pt 1):8-15. PubMed ID: 10075378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous administration of L-arginine inhibits angiotensin-converting enzyme in humans.
    Higashi Y; Oshima T; Ono N; Hiraga H; Yoshimura M; Watanabe M; Matsuura H; Kambe M; Kajiyama G
    J Clin Endocrinol Metab; 1995 Jul; 80(7):2198-202. PubMed ID: 7608279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of increased availability of endothelium-derived nitric oxide precursor on endothelium-dependent vascular relaxation in normal subjects and in patients with essential hypertension.
    Panza JA; Casino PR; Badar DM; Quyyumi AA
    Circulation; 1993 May; 87(5):1475-81. PubMed ID: 8491002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin-(1-7) and nitric oxide interaction in renovascular hypertension.
    Nakamoto H; Ferrario CM; Fuller SB; Robaczewski DL; Winicov E; Dean RH
    Hypertension; 1995 Apr; 25(4 Pt 2):796-802. PubMed ID: 7536715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NO synthase inhibition increases aldosterone in humans.
    Muldowney JA; Davis SN; Vaughan DE; Brown NJ
    Hypertension; 2004 Nov; 44(5):739-45. PubMed ID: 15381675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of L-arginine infusion in normotensive subjects with and without a family history of hypertension.
    Herlitz H; Jungersten LU; Wikstrand J; Widgren BR
    Kidney Int; 1999 Nov; 56(5):1838-45. PubMed ID: 10571792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nitric oxide regulates renal hemodynamics and urinary sodium excretion in dogs.
    Manning RD; Hu L
    Hypertension; 1994 May; 23(5):619-25. PubMed ID: 8175171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of nitric oxide and the renin-angiotensin system in salt-restricted Dahl rats.
    Kataoka H; Otsuka F; Ogura T; Yamauchi T; Kishida M; Takahashi M; Mimura Y; Makino H
    Am J Hypertens; 2001 Mar; 14(3):276-85. PubMed ID: 11281241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of L-arginine and L-NAME on the renal function in hypertensive and normotensive subjects.
    van den Meiracker AH; van der Linde NA; Broere A; Derkx FH; Boomsma F
    Nephron; 2002 Jul; 91(3):444-51. PubMed ID: 12119475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. L-arginine-induced vasodilation in healthy humans: pharmacokinetic-pharmacodynamic relationship.
    Bode-Böger SM; Böger RH; Galland A; Tsikas D; Frölich JC
    Br J Clin Pharmacol; 1998 Nov; 46(5):489-97. PubMed ID: 9833603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.